Quantitative assessment of muscle damage in the mdx mouse model of Duchenne muscular dystrophy using polarization-sensitive optical coherence tomography

Journal of Applied Physiology

Volumn 115, Issue 9, 2013, Pages 1393-1401

  Yang, Xiaojie ^a   Chin, Lixin ^a   Klyen, Blake R ^a   Shavlakadze, Tea ^a   McLaughlin, Robert A ^a   Grounds, Miranda D ^a   Sampson, David D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Birefringence; Mdx mouse; Muscular dystrophy; Necrosis; Polarization sensitive optical coherence tomography

Indexed keywords

ANIMAL; ARTICLE; BIREFRINGENCE; C57BL MOUSE; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; MALE; METHODOLOGY; MOUSE; MUSCULAR DYSTROPHY; NECROSIS; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; POLARIZATION-SENSITIVE OPTICAL COHERENCE TOMOGRAPHY; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

BIREFRINGENCE; MDX MOUSE; MUSCULAR DYSTROPHY; NECROSIS; POLARIZATION-SENSITIVE OPTICAL COHERENCE TOMOGRAPHY;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84887080129     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00265.2013     Document Type: Article

References (54)

1. Adie SG, Hillman TR, Sampson DD. Detection of multiple scattering in optical coherence tomography using the spatial distribution of Stokes vectors. Opt Express 15: 18033-18049, 2007.
2. Amthor H, Egelhof T, McKinnell I, Ladd ME, Janssen I, Weber J, Sinn H, Schrenk HH, Forsting M, Voit T, Straub V. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul Disord 14: 791-796, 2004.
3. Born M, Wolf E. Optics of crystals. In: Principles of Optics. Oxford, UK: Pergamon Press, 1980, p. 665-716.
4. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9: 77-93, 2010.
5. Chin L, Yang X, McLaughlin RA, Noble PB, Sampson DD. En face parametric imaging of tissue birefringence using polarization-sensitive optical coherence tomography. J Biomed Opt 18: 066005, 2013.
6. Colby RH. Intrinsic birefringence of glycerinated myofibrils. J Cell Biol 51: 763-771, 1971.
7. Coulton GR, Morgan JE, Partridge TA, Sloper JC. The mdx mouse skeletal-muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurol 14: 53-70, 1988.
8. Curatolo A, McLaughlin RA, Quirk BC, Kirk RW, Bourke AG, Wood BA, Robbins PD, Saunders CM, Sampson DD. Ultrasoundguided optical coherence tomography needle probe for the assessment of breast cancer tumor margins. Am J Roentgenol 199: W520-W522, 2012.
9. De Boer JF, Milner TE. Review of polarization sensitive optical coherence tomography and Stokes vector determination. J Biomed Opt 7: 359-371, 2002.
10. Fercher AF, Drexler W, Hitzenberger CK, Lasser T. Optical coherence tomography-principles and applications. Rep Prog Phys 66: 239-303, 2003.
11. Foster FS, Pavlin CJ, Harasiewicz KA, Christopher DA, Turnbull DH. Advances in ultrasound biomicroscopy. Ultrasound Med Biol 26: 1-27, 2000.
12. Frank M, Beneker J, Ekkernkamp A. Respiratory failure due to Duchenne muscular dystrophy. Notarzt 24: 59-60, 2008.
13. Fujimoto JG. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol 21: 1361-1367, 2003.
14. Gilbert RK, Hawk WA. The incidence of necrosis of muscle fibers in Duchenne type muscular dystrophy. Am J Pathol 43: 107-122, 1963.
15. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 31: 1-19, 2008.
16. Grounds MD, Torrisi J. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 18: 676 -682, 2004.
17. Hamer PW, McGeachie JM, Davies MJ, Grounds MD. Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat 200: 69-79, 2002.
18. Haskell RC, Carlson FD, Blank PS. Form birefringence of muscle. Biophys J 56: 401-413, 1989.
19. Hee MR, Huang D, Swanson EA, Fujimoto JG. Polarization-sensitive low-coherence reflectometer for birefringence characterization and ranging. J Opt Soc Am B 9: 903-908, 1992.
20. Hsiung PL, Nambiar PR, Fujimoto JG. Effect of tissue preservation on imaging using ultrahigh resolution optical coherence tomography. J Biomed Opt 10: 064033, 2005.
21. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, Fujimoto JG. Optical coherence tomography. Science 254: 1178-1181, 1991.
22. Jacoby AS, Busch-Nentwich E, Bryson-Richardson RJ, Hall TE, Berger J, Berger S, Sonntag C, Sachs C, Geisler R, Stemple DL, Currie PD. The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment. Development 136: 3367-3376, 2009.
23. Klyen BR, Armstrong JJ, Adie SG, Radley HG, Grounds MD, Sampson DD. Three-dimensional optical coherence tomography of wholemuscle autografts as a precursor to morphological assessment of muscular dystrophy in mice. J Biomed Opt 13: 011003, 2008.
24. Klyen BR, Shavlakadze T, Radley-Crabb HG, Grounds MD, Sampson DD. Identification of muscle necrosis in the mdx mouse model of Duchenne muscular dystrophy using three-dimensional optical coherence tomography. J Biomed Opt 16: 076013, 2011.
25. Kobayashi M, Nakamura A, Hasegawa D, Fujita M, Orima H, Takeda S. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 40: 815-826, 2009.
26. Kornegay JN, Li J, Bogan JR, Bogan DJ, Chen C, Zheng H, Wang B, Qiao C, Howard JF Jr, Xiao X. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther 18: 1501-1508, 2010.
27. Liew YM, McLaughlin RA, Gong P, Wood FM, Sampson DD. In vivo assessment of human burn scars through automated quantification of vascularity using optical coherence tomography. J Biomed Opt 18: 061213, 2013.
28. Liew YM, McLaughlin RA, Wood FM, Sampson DD. Reduction of image artifacts in three-dimensional optical coherence tomography of skin in vivo. J Biomed Opt 16: 116018, 2011.
29. Lorenser D, Yang X, Kirk RW, Quirk BC, McLaughlin RA, Sampson DD. Ultrathin side-viewing needle probe for optical coherence tomography. Opt Lett 36: 3894-3896, 2011.
30. Manzur AY, Muntoni F. Diagnosis and new treatments in muscular dystrophies. Postgrad Med J 85: 622-630, 2009.
31. McIntosh LM, Baker BE, Anderson JE. Magnetic resonance imaging of regenerating and dystrophic mouse muscle. Biochem Cell Biol 76: 532-541, 1998.
32. McLaughlin RA, Yang X, Quirk BC, Lorenser D, Kirk RW, Noble PB, Sampson DD. Static and dynamic imaging of alveoli using optical coherence tomography needle probes. J Appl Physiol 113: 967-974, 2012.
33. Pasquesi JJ, Schlachter SC, Boppart MD, Chaney E, Kaufman SJ, Boppart SA. In vivo detection of exercise-induced ultrastructural changes in genetically-altered murine skeletal muscle using polarization- sensitive optical coherence tomography. Opt Express 14: 1547-1556, 2006.
34. Pierce MC, Park BH, Cense B, De Boer JF. Simultaneous intensity, birefringence, and flow measurements with high-speed fiber-based optical coherence tomography. Opt Lett 27: 1534-1536, 2002.
35. Quirk BC, McLaughlin RA, Curatolo A, Kirk RW, Noble PB, Sampson DD. In situ imaging of lung alveoli with an optical coherence tomography needle probe. J Biomed Opt 16: 036009, 2011.
36. Radley-Crabb H, Terrill J, Shavlakadze T, Tonkin J, Arthur P, Grounds M. A single 30 min treadmill exercise session is suitable for "proof-of concept studies" in adult mdx mice: a comparison of the early consequences of two different treadmill protocols. Neuromuscul Disord 22: 170-182, 2012.
37. Radley HG, De Luca A, Lynch GS, Grounds MD. Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int J Biochem Cell B 39: 469-477, 2007.
38. Sampson DD. Optical bioimaging 2010: seeing more, deeper, faster. IEEE Photonics J 3: 278-283, 2011.
39. Schambach SJ, Bag S, Schilling L, Groden C, Brockmann MA. Application of micro-CT in small animal imaging. Methods 50: 2-13, 2010.
40. Schambach SJ, Bag S, Steil V, Isaza C, Schilling L, Groden C, Brockmann MA. Ultrafast high-resolution in vivo volume-CTA of mice cerebral vessels. Stroke 40: 1444-1450, 2009.
41. Shavlakadze T, White J, Hoh JF, Rosenthal N, Grounds MD. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice. Mol Ther 10: 829-843, 2004.
42. Sipila S, Suominen H. Ultrasound imaging of the quadriceps muscle in elderly athletes and untrained men. Muscle Nerve 14: 527-533, 1991.
43. Straub V, Donahue KM, Allamand V, Davisson RL, Kim YR, Campbell KP. Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn Reson Med 44: 655-659, 2000.
44. Swash M, Brown MM, Thakkar C. CT muscle imaging and the clinical-assessment of neuromuscular disease. Muscle Nerve 18: 708 - 714, 1995.
45. Van Erp C, Irwin NG, Hoey AJ. Long-term administration of pirfenidone improves cardiac function in mdx mice. Muscle Nerve 34: 327-334, 2006.
46. Wallace KD, Marsh JN, Baldwin SL, Connolly AM, Keeling R, Lanza GM, Wickline SA, Hughes MS. Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropybased radio frequency signal processing. IEEE Trans Ultrason Ferroelectr Freq Control 54: 2291-2299, 2007.
47. Walter G, Cordier L, Bloy D, Sweeney HL. Noninvasive monitoring of gene correction in dystrophic muscle. Magn Reson Med 54: 1369 - 1376, 2005.
48. Ward SR, Lieber RL. Density and hydration of fresh and fixed human skeletal muscle. J Biomech 38: 2317-2320, 2005.
49. Wieser W, Biedermann BR, Klein T, Eigenwillig CM, Huber R. Multimegahertz OCT: high quality 3D imaging at 20 million A-scans and 4.5 GVoxels per second. Opt Express 18: 14685-14704, 2010.
50. Willmann R, De Luca A, Benatar M, Grounds M, Dubach J, Raymackers JM, Nagaraju K, Network TN. Enhancing translation: guide-lines for standard pre-clinical experiments in mdx mice. Neuromuscul Disord 22: 43-49, 2012.
51. Wu YC, Xi JF, Huo L, Padvorac J, Shin EJ, Giday SA, Lennon AM, Canto MI, Hwang JH, Li XD. Robust high-resolution fine OCT needle for sideviewing interstitial tissue imaging. IEEE J Sel Top Quant 16: 863-869, 2010.
52. Yeh Y, Baskin RJ, Brown RA, Burton K. Depolarization spectrum of diffracted light from muscle fiber-the intrinsic anisotropy component. Biophys J 47: 739-742, 1985.
53. Zhu XY, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, Caplice N, Ritman EL, Lerman A, Lerman LO. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109: 2109 -2115, 2004.
54. Zubrzyckagaarn EF, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333: 466 -469, 1988.